Back to search

Article

Canagliflozin Alleviates Diabetic Cardiovascular Disease via Lipid Lowering, Mitochondrial Homeostasis, and Gut Microbiota Regulation

2021-08-12

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Type 2 diabetes mellitus (T2DM) is associated with cardiovascular disease (CVD). Sodium glucose cotransporter 2 inhibitors (SGLT2i) represent the most effective oral drugs for the treatment of T2DM, and have been shown to improve generalized vascular dysfunction. However, it’s effect on improving diabetic CVD and the possible action mechanism are currently uncle...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ae393b01-2567-5174-b9cf-3b41cd9340c0
DOI
10.21203/rs.3.rs-754308/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Canagliflozin Alleviates Diabetic Cardiovascular Disease via Lipid Lowering, Mitochondrial Homeostasis, and Gut Microbiota RegulationDOI 10.21203/rs.3.rs-754308/v1
Select a neighboring publication to make it the new centre.